NewsData4d ago
Sun Pharma gets Brazil nod for Semaglutide
From the publisher
Sun Pharma receives ANVISA approval to launch semaglutide in Brazil, expanding diabetes treatment options in a $413 million market.
The source's own excerpt, unedited
From the publisher
Sun Pharma receives ANVISA approval to launch semaglutide in Brazil, expanding diabetes treatment options in a $413 million market.
The source's own excerpt, unedited
Discussion
Talk through this story with your campus.
No comments yet.
Be the first to share your take.